APA (7th ed.) Citation

X, W., D, Q., W, L., K, W., W, W., Y, Z., . . . X, Q. (2025). Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. Gut, 75(1), 147. https://doi.org/10.1136/gutjnl-2025-335456

Chicago Style (17th ed.) Citation

X, Wu, et al. "Clinical Results of an HBV-specific T-cell Receptor-T-cell Therapy (SCG101) in Patients with HBV-related Hepatocellular Carcinoma Treated in an Investigator-initiated, Interventional Trial." Gut 75, no. 1 (2025): 147. https://doi.org/10.1136/gutjnl-2025-335456.

MLA (9th ed.) Citation

X, Wu, et al. "Clinical Results of an HBV-specific T-cell Receptor-T-cell Therapy (SCG101) in Patients with HBV-related Hepatocellular Carcinoma Treated in an Investigator-initiated, Interventional Trial." Gut, vol. 75, no. 1, 2025, p. 147, https://doi.org/10.1136/gutjnl-2025-335456.